Research and Industry Collaboration Opportunities

Enterprise Innovation brings internal and external collaboration opportunities to our faculty and trainees. These programs provide extra funding and opportunities to work with industry to advance faculty/trainees' translational research projects. 

Please contact Dr. James Bellush at james.bellush@cornell.edu if you have any questions or need guidance on your application.

1. Sanders Tri-I TDI Therapeutic Small Molecule Projects

Objective: Advance early-stage projects, that have the potential to benefit patients, to proof of concept studies. TDI contributes medicinal chemistry and drug development capabilities that complement the deep scientific expertise already available in our research community.

Eligibility:

  • Principal Investigators whose full-time employer is The Rockefeller University, Weill Cornell Medicine, or Memorial Sloan Kettering.
  • Investigators who may have a faculty appointment at at any of the above institutes, but who are not full-time employees of any of these institutes are not eligible.
  • Only small molecule chemical compounds will be considered.

Funding and Budgeting

  • Full applications will require a clear metric-driven critical path to inform go/no go decisions and a budget.
  • Continued support will be success-driven and subject to completion of predefined project milestones.
  • TDI will support medicinal chemistry costs and provide assay development and execution expertise.
  • TDI does NOT provide direct funding support, only in-kind service support.
  • Each PI will be responsible for the cost of activities in his/ her lab.
  • Beginning in 2024 PI labs will be charged 10% of the actual cost of their program, capped at $100K for the life of the program. Please note that the cost of a 3 – 5 year therapeutic discovery project is typically $2- 5M.

Submission Process

  • All submissions must be in Adobe Reader (.pdf)
  • Full proposals should be submitted through the “Submit Application” button at the top of this page, which will be active after LOI submissions are complete.

2. 2025 American Heart Association: Merit Award

  • Eligibility: Tenured / tenure-track professors (AHA members) with multiple federal grants and stellar publication record who are proposing novel, high impact approaches to cardiovascular and cerebrovascular diseases research.
  • RFP Details: Applicants must submit a LOI through ProposalCentral portal
  • Award Details: $200k annually for 5 yrs = $1,000,000 per award
  • Submission Deadline: Tuesday, September 10, 2024 @ 3pm CT

 3. 2025 American Heart Association: Established Investigator Award

  • Eligibility: Cardiovascular or cerebrovascular researchers at associate professor level who are proposing a novel research direction that challenges existing experimental or technological paradigms.
  • RFP Details: Applicants must submit a pre-proposal via ProposalCentral containing:
    • Two-page research summary and LOI
    • List of 15 most impactful publications
    • NIH Biosketch and details for last 5 yrs of research funding
    • Project summary
    • Award Details: $110k annually for 5 yrs = $550,000 per award
    • Submission Deadline: Wednesday, October 2, 2024 @ 3pm CT

4. 2025 American Heart Association: Collaborative Sciences Award

  • Eligibility: Team consisting of 2-4 early – mid career investigators from disparate disciplines (one must be in cardiovascular research, one must be in divergent discipline) proposing a collaborative research project .
  • RFP Details: Teams must submit one application jointly, consisting of a three-page, pre-proposal summary of the scientific objectives and detailing the interdisciplinary team’s expertise.
  • Award Details: $333k annually for 3 yrs = $1,000,000 per award
  • Submission Deadline: Thursday, October 3, 2024

5. Pfizer: PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing metastatic Castration Resistant Prostate Cancer (mCRPC) landscape

  • Eligibility: US based investigators focused on evaluating PARP inhibitors (PARPi) in the treatment of metastatic castration resistant prostate cancer (mCRPC), specifically:
    • MOA and clinical rationale for PARPi combinations
    • Clinical safety, treatment sequencing, and patient subgroup data
    • Best practices in interpreting biomarker + genetic data for treatment
    • Clinical data regarding PARPi combination vs. monotherapy

6. Parkinson’s Foundation: Impact Award

  • Eligibility: Tenure-track investigators pursuing “outside the box” projects which seek to shed light on novel Parkinson’s disease biology, incorporate a novel research approach, or test a truly novel therapeutic concept. 
    • Proposals should be testing groundbreaking or unconventional ideas which are unlikely to receive funding from traditional mechanisms.
    • Additional interest areas include: new PD biomarkers, new intervention targets, and co-pathologies in PD
    • Established PD researchers or newcomers to PD field encouraged to apply
  • Submission Details: Please submit a one-page LOI by specified deadline.  If selected after peer review, the applicant will be invited to submit a full proposal
  • Award Details: $150,000 for 12-18 months (up to 10% may be used for IDC)
  • Submission Deadline: October 31, 2024

7. Barth Syndrome Foundation: 2025 Grant Cycle

  • Eligibility: Young and established tenure track investigators with a focus on addressing the basic, translational, and clinical research challenges of Barth syndrome. 
    • Successful proposals aim to generate preliminary data that would catalyze follow-on funding from institutions like the NIH.
    • Applications will be evaluated based on: 1) research importance / impact, 2) feasibility and investigator qualifications, and 3) prospect for long-term funding
  • Submission Details: Submit full application via the portal
  • Award Details: $100,000 maximum for 1-3 yrs duration
  • Submission Deadline: November 1, 2024

8. Cystic Fibrosis Research Institute: New Horizons Research Program

  • Eligibility: Tenure track investigators conducting pioneering basic or translational research aimed at finding improved treatments for cystic fibrosis.  New Horizon awards are focused on providing seed funding for promising new lines of research which show prospects of future funding by NIH.
    • Priority is given to proposals of superior scientific quality
  • Submission Details: Submit LOI to CFRI by November 3, 2024 @ 11:59pm ET
  • Award Details: Total of $140,000 available in funding over two years ($70k per year)
  • Submission Deadline: November 4, 2024

9. Cystic Fibrosis Research Institute: Elizabeth Nash Memorial Fellowship

  • Eligibility: Post-doctoral fellows with a research focus on cystic fibrosis, specifically related to genetics, biological mechanisms, translational drug discovery, and clinical management of CF.
  • Priority is given to original projects aiming to explore novel therapeutic pathway, targets, or modality
  • Submission Details: Submit an LOI to CFRI by November 4, 2024.  Full proposals by invitation only.
  • Award Details: Total of $130,000 over two years ($65k/year)
  • Submission Deadline: November 4, 2024

10. National Science Foundation: Collaborative Research in Computational Neuroscience (CRCNS)

  • Eligibility: Principal investigators utilizing computational approaches to accelerate understanding of nervous system structure, function, and mechanisms of CNS disorders. 
  • Two types of proposals will be considered:
  • Collaborative grant structure involving two or more participating institutions and investigators (domestic + international collaborations considered)
      • Research Proposals
      • Data Sharing Proposals
  • Submission Details: Submit research proposal via Grants.gov in accordance with program solicitation instructions
  • Award Details: Award size ranges from $100k-$250k per year for 3-5 years (up to $1.2M based on project specific budget requirements)
  • Submission Deadline: November 13, 2024

11. Society of Surgical Oncology: Clinical Investigator Award

  • Eligibility: Early – mid career surgical oncologist (SSO member, at least 8 yrs post-fellowship) with proven track record of peer-reviewed research funding, who is proposing a clinical or translational project with the potential to bring transformative benefit to patients
  • Submission Details: Apply directly via the SSO portal
  • Application Materials:
      • Online application form
      • NIH Biosketch
      • Letters of Support (min. 1, max. 3)
      • Research Proposal (Abstract, Research Plan, Resources, Literature, Budget, Appendix)
  • Award Details: $100k over 2 years ($50k/yr)
  • Submission Deadline: November 15, 2024

12. Cancer Research Institute: Technology Impact Award

  • Eligibility: CRI grant designed to encourage collaboration between technology developers and clinical cancer immunologists for the generation of proof of principle data relating to novel technology platform, including:

Bioinformatics
Ex vivo or in silico modeling systems
Immunological or tumor profiling instrumentation
Methods
Reagents and assays
Other technologies to provide clinicians deeper insights into MOA or treatment efficacy

  • Submission Details: Complete the online LOI form by November 15
  • Award Details: $200k seed funding to be used over 12-24 months
  • Submission Deadline: November 15, 2024

13. Gerber Foundation: Pediatric Research Grants

  • Eligibility: Principal investigators focused on historically challenging or emerging pediatric health issues.  Proposals should aim to improve the health, nutrition, and / or developmental outcomes for infants and young children.
  • Priority will be given to proposals offering practical solutions that can be easily and rapidly implemented on a broad scale with manageable time frame to clinical application in areas such as:
      • Respiratory disease
      • Growth, nutrition, metabolism, microbiome
      • Cardiology
      • Ophthalmology
      • Nephrology
      • Childhood cancers
      • Neurodevelopment
  • Submission Details: Submit concept paper summary through online portal, full proposals by invitation only.
  • Award Details: Up to $350k in funding (including IDC) over 3 years
  • Submission Deadline: November 15, 2024

14. 2025 American Heart Association: Career Development Award

  • Eligibility: Investigators within 6 years of their first faculty appointment (assistant professor or equivalent) who are exploring innovative questions or pilot studies that will provide the preliminary data to assure future success.
  • RFP Details: Submission requires a three-page career development plan and award requires appointing a primary and secondary mentor
  • Award Details: $77k annually for 3 yrs = $231k per award
  • Submission Deadline: Thursday, December 5, 2024

15. 2025 American Heart Association: Innovative Project Award

  • Eligibility: Ph.D. researchers (no requirement for faculty appointment) pursuing highly innovative, unexplored, creative ideas which will accelerate cardiovascular or cerebrovascular science. 
  • RFP Details: Preliminary data is not required and will not be accepted. A solid rationale for the proposed research idea must be provided in a one page pre-proposal, available via ProposalCentral
  • Award Details: $100k annually for 2 yrs = $200k per award
  • Submission Deadline: Thursday, December 5, 2024